Page last updated: 2024-08-21

cyproterone acetate and Coronary Artery Disease

cyproterone acetate has been researched along with Coronary Artery Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cerquetani, E; Fini, M; Leonardo, F; Onorati, D; Rosano, GM; Rossini, P; Vitale, C1

Trials

1 trial(s) available for cyproterone acetate and Coronary Artery Disease

ArticleYear
Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease.
    Maturitas, 2001, Dec-14, Volume: 40, Issue:3

    Topics: Brachial Artery; Coronary Artery Disease; Cross-Over Studies; Cyproterone Acetate; Double-Blind Method; Drug Administration Schedule; Endothelin-1; Endothelium, Vascular; Estradiol; Estrogens, Conjugated (USP); Female; Forearm; Hormone Replacement Therapy; Humans; Middle Aged; Postmenopause; Progesterone Congeners; Regional Blood Flow; Treatment Outcome

2001